SCM
NVRO

Sandler Capital Management’s NEVRO CORP. NVRO Stock Holding History

Sandler Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-44,840
Closed -$3.31M – 146
2016
Q2 		$3.31M Buy
+44,840
New +$3.04M 0.44% 79

Other funds holding NVRO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sandler Capital Management's NVRO Position: Q3 2016 in Review

Sandler Capital Management sold out of NEVRO CORP. (NVRO) in Q3 2016, closing a stake of 44,840 shares — an estimated $3.31M sold.

Sandler Capital Management first reported a position in NVRO in Q2 2016 and held it in 1 quarter. The position peaked at $3.31M in Q2 2016. 192 funds tracked by Wall St. Rank hold NVRO as of Q3 2016.

  • Sandler Capital Management reported no remaining NEVRO CORP. position as of Q3 2016 after selling out during the quarter.
  • Sandler Capital Management sold 44,840 NEVRO CORP. shares in Q3 2016, an estimated $3.31M.
  • Sandler Capital Management first reported a position in NEVRO CORP. in Q2 2016 and held it in 1 quarter.
  • Sandler Capital Management's NEVRO CORP. position peaked at $3.31M in Q2 2016.
  • 192 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2016.

Based on Sandler Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.